Health Condition 1: C50- Malignant neoplasm of breast
Conditions
Interventions
Intervention1: Homoeopathic Medicines: 6 Months enrollment
6 months Follow up
3 months analysis
Oral route of administration
Pill form- 30 Globule size
Centesimal Scale
First dose after taking the ca
Sponsors
Bakson Homoeopathic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Confirmed cases of breast cancer undergoing chemotherapy. Patient willing to sign the informed consent. Patient having adverse effects of chemotherapy. such as nausea vomiting diarrhea constipation dry mouth mucositis hair loss sensory neuropathy. myalgia fatigue with CTC grading I to III.
Exclusion criteria
Exclusion criteria: Patient with mentioned adverse effects of CTC grade IV will not be considered. Comatose patients and non-ambulatory patients. Patients with uncontrolled systemic diseases and/or pathologies, psychiatric illness with cognitive impairment. Patients with ongoing use of homeopathic medicines for any other diseases in the last 2 weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is Expected to Have Positive Changes on CTC scale.Timepoint: 15 Months Study 6 Months Enrollment 6 Months Follow Up CTC Gradation score to be done at baseline and further according to chemotherapy regime. 3 Months Data Analysis | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: Not Applicable | — |
Countries
India
Contacts
Public ContactDr Neha Nagar
Bakson Homoeopathic Medical College and Hospital
Outcome results
None listed